High T-cell immune activation and immune exhaustion among individuals with suboptimal CD4 recovery after 4 years of antiretroviral therapy in an African cohort (Q30999041)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	High T-cell immune activation and immune exhaustion among individuals with suboptimal CD4 recovery after 4 years of antiretroviral therapy in an African cohort	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

5 November 2017

High T-cell immune activation and immune exhaustion among individuals with suboptimal CD4 recovery after 4 years of antiretroviral therapy in an African cohort (English)

1 reference

Europe PubMed Central

PMC publication ID

5 November 2017

anti-retroviral agent

0 references

Damalie Nakanjako

object named as

Damalie Nakanjako

1

0 references

Harriet Mayanja-Kizza

object named as

Harriet Mayanja-Kizza

3

0 references

8

object named as

Moses R Kamya

1 reference

Europe PubMed Central

PMC publication ID

5 November 2017

Robert Colebunders

5

object named as

Robert Colebunders

1 reference

Europe PubMed Central

PMC publication ID

5 November 2017

4

object named as

Agnes Kiragga

1 reference

Europe PubMed Central

PMC publication ID

5 November 2017

author name string

Isaac Ssewanyana

2

1 reference

Europe PubMed Central

PMC publication ID

5 November 2017

Yukari C Manabe

6

1 reference

Europe PubMed Central

PMC publication ID

5 November 2017

Rose Nabatanzi

7

1 reference

Europe PubMed Central

PMC publication ID

5 November 2017

Huyen Cao

9

1 reference

Europe PubMed Central

PMC publication ID

5 November 2017

publication date

8 February 2011

1 reference

Europe PubMed Central

PMC publication ID

5 November 2017

BMC Infectious Diseases

1 reference

Europe PubMed Central

PMC publication ID

5 November 2017

11

1 reference

Europe PubMed Central

PMC publication ID

5 November 2017

43

1 reference

Europe PubMed Central

PMC publication ID

5 November 2017

copyright license

Creative Commons Attribution 2.0 Generic

8 February 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

1 reference

April 2022 Public Data File from Crossref

CD4+ T cell depletion, immune activation and increased production of regulatory T cells in the thymus of HIV-infected individuals

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065409

21 June 2018

Mortality reduction associated with HIV/AIDS care and antiretroviral treatment in rural Malawi: evidence from registers, coffin sales and funerals

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065409

21 June 2018

Incomplete peripheral CD4+ cell count restoration in HIV-infected patients receiving long-term antiretroviral treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065409

21 June 2018

The Distribution and Immune Profile of T Cell Subsets in HIV-Infected Children from Uganda

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065409

21 June 2018

The absence of CD4+ T cell count recovery despite receipt of virologically suppressive highly active antiretroviral therapy: clinical risk, immunological gaps, and therapeutic options

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065409

21 June 2018

Changing mortality risk associated with CD4 cell response to antiretroviral therapy in South Africa

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065409

21 June 2018

Sub-optimal CD4 reconstitution despite viral suppression in an urban cohort on antiretroviral therapy (ART) in sub-Saharan Africa: frequency and clinical significance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065409

21 June 2018

Human immunodeficiency virus (HIV-1) infection selectively downregulates PD-1 expression in infected cells and protects the cells from early apoptosis in vitro and in vivo.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065409

21 June 2018

Scaling up antiretroviral therapy in South Africa: the impact of speed on survival

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065409

21 June 2018

Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065409

21 June 2018

Predictors of long-term viral failure among ugandan children and adults treated with antiretroviral therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065409

21 June 2018

Profile of immunologic recovery in HIV-infected Ugandan adults after antiretroviral therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065409

21 June 2018

Feasibility and effectiveness of cotrimoxazole prophylaxis for HIV-1-infected adults attending an HIV/AIDS clinic in Uganda

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065409

21 June 2018

Effect of co-trimoxazole prophylaxis, antiretroviral therapy, and insecticide-treated bednets on the frequency of malaria in HIV-1-infected adults in Uganda: a prospective cohort study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065409

21 June 2018

Effect of home-based water chlorination and safe storage on diarrhea among persons with human immunodeficiency virus in Uganda.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065409

21 June 2018

The CCR5 receptor-based mechanism of action of 873140, a potent allosteric noncompetitive HIV entry inhibitor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065409

21 June 2018

T Cell Activation Is Associated with Lower CD4+T Cell Gains in Human Immunodeficiency Virus–Infected Patients with Sustained Viral Suppression during Antiretroviral Therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065409

21 June 2018

Immune restoration after treatment of HIV-1 infection with highly active antiretroviral therapy (HAART).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065409

21 June 2018

Differences in cellular activation and apoptosis in HIV-infected patients receiving protease inhibitors or nonnucleoside reverse transcriptase inhibitors.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-11-43

21 January 2018

Immune activation in patients infected with HIV type 1 and maintaining suppression of viral replication by highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-11-43

21 January 2018

CD8+CD38+ T cells but not HIV type 1 RNA viral load predict CD4+ T cell loss in a predominantly minority female HIV+ adolescent population

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-11-43

21 January 2018

Persistent microbial translocation and immune activation in HIV-1-infected South Africans receiving combination antiretroviral therapy.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-11-43

21 January 2018

Helminths, human immunodeficiency virus and tuberculosis

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-11-43

21 January 2018

Programmed death (PD)-1 molecule and its ligand PD-L1 distribution among memory CD4 and CD8 T cell subsets in human immunodeficiency virus-1-infected individuals

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-11-43

21 January 2018

Poor CD4 T cell restoration after suppression of HIV-1 replication may reflect lower thymic function

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-11-43

21 January 2018

Association between malaria and CD4 cell count decline among persons with HIV.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-11-43

21 January 2018

Immune activation, apoptosis, and Treg activity are associated with persistently reduced CD4+ T-cell counts during antiretroviral therapy.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-11-43

21 January 2018

CD4 T-cell hyperactivation and susceptibility to cell death determine poor CD4 T-cell recovery during suppressive HAART

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-11-43

21 January 2018

Nadir CD4 T Cell Count as Predictor and High CD4 T Cell Intrinsic Apoptosis as Final Mechanism of Poor CD4 T Cell Recovery in Virologically Suppressed HIV‐Infected Patients: Clinical Implications

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-11-43

21 January 2018

Characteristics, Determinants, and Clinical Relevance of CD4 T Cell Recovery to <500 Cells/ L in HIV Type 1--Infected Individuals Receiving Potent Antiretroviral Therapy

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-11-43

21 January 2018

Changes in blood CD8+ lymphocyte activation status and plasma HIV RNA levels during antiretroviral therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/21299909

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CCR5 and CXCR4 chemokine receptor expression and beta-chemokine production during early T cell repopulation induced by highly active anti-retroviral therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/21299909

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CD4+ T cell recovery beyond the first year of complete suppression of viral replication during highly active antiretroviral therapy is not influenced by CD8+ T cell activation

1 reference

https://pubmed.ncbi.nlm.nih.gov/21299909

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of PD-L1, a marker of disease status, is not reduced by HAART in aviraemic patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/21299909

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Programmed death 1 expression on HIV-specific CD4+ T cells is driven by viral replication and associated with T cell dysfunction

1 reference

https://pubmed.ncbi.nlm.nih.gov/21299909

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Discordant responses to HAART in HIV-1 patients: the need to focus on intervention

1 reference

https://pubmed.ncbi.nlm.nih.gov/21299909

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1471-2334-11-43

1 reference

Europe PubMed Central

PMC publication ID

5 November 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

5 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

5 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30999041&oldid=2195057994"